Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–25 of 195 articles for Clozapine

Then save them, add them to a collection or cite them together.
  1. Research article · 10 Jul 2009

    Clozapine for Treatment-Resistant Schizophrenia: National Institute of Clinical Excellence (NICE) Guidance in the Real World

    Clinical Schizophrenia & Related Psychoses · Volume 4, Issue 2

    Introduction: Clozapine, a poorly tolerated antipsychotic drug, is widely recognized as the only efficacious option in treatment-resistant psychosis. The United Kingdom (U.K.) National Institute of Clinical Excellence…

  2. Conference abstract · 25 Aug 2015

    Priapism associated with the use of clozapine. Case report

    more common in medical practice. Priapism is predictable side effect of atypical antipsychotics, particularly clozapine. For a 54 year old patient with a history of schizophrenia who received 300mg ... drug treatment…

  3. Short communication · 31 Jul 2020

    Pharma Europe 2020 : Clozapine attenuated mitochondrial dysfunction, inflammatory gene expression,and behavioural abnormalities in an animal model of schizophrenia-Mir-Jamal Hossein -Tehran University of Medical Sciences

    International Research Journal of Pharmacy and Pharmacology · Volume 8, Issue 3

    normal and stressed rats and then, each group were divided into treatment (clozapine; CLZ, 2.5 mg/kg/day for 28 days) and non-treatment groups. Results: Our data showed that ... occurring medical conditions, such as…

  4. Research article · 27 Feb 2009

    An Archival, Follow-Forward Exploration of the Metabolic Syndrome in Randomly Selected, Clozapine-Treated Patients

    Clinical Schizophrenia & Related Psychoses · Volume 3, Issue 3

    Objectives: Cross-sectional studies indicate that clozapine is associated with unusually high rates of the metabolic syndrome (MetS) in schizophrenia. These studies cannot address the extent to which schizophrenia…

  5. Research article · 13 May 2011

    Underprescribing of Clozapine and Unexplained Variation in Use across Hospitals and Regions in the Canadian Province of Québec

    Clinical Schizophrenia & Related Psychoses · Volume 7, Issue 2

    Background: Clozapine remains the antipsychotic of choice for people who, having met the criteria for a diagnosis of schizophrenia or a related psychotic disorder, do not respond adequately to other ... variable across…

  6. Article · 8 May 2007

    Clozapine and Dilated Cardiomyopathy

    Clinical Schizophrenia & Related Psychoses · Volume 1, Issue 2

    Clozapine is effective in treatment-resistant schizophrenia, but carries a number of risks, including the rare but potentially fatal complication of cardiomyopathy. We report the case of a long-term ... inpatient with…

  7. Research article · 6 Nov 2017

    Lack of Pharmacokinetic Interaction between Antipsychotics (Quetiapine, Clozapine and Olanzapine) and the Beta-Blockers Metoprolol, Propranolol, Bisoprolol and Nebivolol Except between Carvedilol and the Antipsychotics Quetiapine and Clozapine

    Journal of Analytical & Bioanalytical Techniques · Volume 8, Issue 6

    this study was to evaluate a potential pharmacokinetic interaction between antipsychotics (quetiapine QUE, clozapine CLO and olanzapine OLA) and beta-blockers (metoprolol MET, propranolol PRO, bisoprolol BIS, nebivolol

  8. Research article · 27 Aug 2020

    Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder

    Clinical Schizophrenia & Related Psychoses · Volume 13, Issue 2

    goal of this 21-year naturalistic study of clozapine-treated patients was to examine the cardiovascular risk factors following clozapine initiation and resultant mortality estimates from cardiovascular disease. Data…

  9. Commentary · 15 Feb 2007

    Why Not Clozapine?

    Clinical Schizophrenia & Related Psychoses · Volume 1, Issue 1

    Clozapine is the only antipsychotic medication approved for treatment-resistant schizophrenia. The superiority of this second-line antipsychotic for reducing positive psychotic symptoms compared to other antipsychotics…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels